Literature DB >> 9707883

Fluconazole in visceral leishmaniasis.

B B Jha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9707883

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


× No keyword cloud information.
  3 in total

1.  Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.

Authors:  Nishi Shakya; Shraddha A Sane; Suman Gupta
Journal:  Parasitol Res       Date:  2011-01-07       Impact factor: 2.289

2.  Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs.

Authors:  Nishi Shakya; Preeti Bajpai; Suman Gupta
Journal:  J Parasit Dis       Date:  2011-05-20

Review 3.  Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.

Authors:  Om Prakash Singh; Bhawana Singh; Jaya Chakravarty; Shyam Sundar
Journal:  Infect Dis Poverty       Date:  2016-03-08       Impact factor: 4.520
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.